MarketCap
Facebook
X
TelegramItamar Medical Ltd. General and Administrative Expenses 2011-2025 | ITMR
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses Itamar Medical Ltd.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 8.5 M | 6.35 M | 5.25 M | 5.28 M | 5.36 M | 4.3 M | 4.63 M | 4.88 M | 2.54 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.5 M | 2.54 M | 5.23 M |
General and Administrative Expenses of other stocks in the Medical devices industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
334 M | - | - | $ 17.2 B |  USA |
 |
Alphatec Holdings
ATEC
|
450 M | $ 20.95 | -0.1 % | $ 2.99 B | USA |
 |
Acutus Medical
AFIB
|
14.1 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
7.11 M | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
25.6 M | - | - | $ 1.77 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
163 M | $ 9.28 | -0.32 % | $ 666 M |  Israel |
 |
Apyx Medical Corporation
APYX
|
22.2 M | $ 3.54 | 2.91 % | $ 123 M | USA |
 |
Boston Scientific Corporation
BSX
|
5.98 B | $ 95.79 | -0.24 % | $ 141 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
8.78 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
814 M | $ 303.53 | -0.15 % | $ 8.56 B | USA |
 |
Apollo Endosurgery
APEN
|
20.6 M | - | - | $ 475 M | USA |
 |
Conformis
CFMS
|
28.8 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
171 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
63.3 M | - | -10.19 % | $ 1.99 M | USA |
 |
BioSig Technologies
BSGM
|
11.6 M | - | 37.08 % | $ 85.7 M | USA |
 |
Electromed
ELMD
|
39.3 M | $ 28.33 | -0.6 % | $ 240 M | USA |
 |
Bruker Corporation
BRKR
|
894 M | $ 48.37 | 0.74 % | $ 7.21 K | USA |
 |
Abbott Laboratories
ABT
|
11.7 B | $ 124.66 | -0.14 % | $ 217 B | USA |
 |
Eargo
EAR
|
54.3 M | - | - | $ 10.2 M | USA |
 |
EDAP TMS S.A.
EDAP
|
5.9 M | $ 3.25 | -4.41 % | $ 121 M |  France |
 |
CryoLife, Inc.
CRY
|
141 M | - | -4.14 % | $ 702 M | USA |
 |
Soliton, Inc.
SOLY
|
8.46 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.88 K | - | -1.98 % | $ 98.3 M | USA |
 |
Misonix, Inc.
MSON
|
18 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14.7 M | - | - | $ 111 M |  Canada |
 |
InMode Ltd.
INMD
|
8.41 M | $ 14.81 | 1.3 % | $ 1.17 B | Israel |
 |
IRIDEX Corporation
IRIX
|
8.75 M | $ 1.17 | -4.88 % | $ 18.9 M | USA |
 |
IRadimed Corporation
IRMD
|
15.9 M | $ 97.65 | 0.21 % | $ 1.24 B | USA |
 |
Dynatronics Corporation
DYNT
|
8.46 M | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
98.6 M | - | - | $ 955 M | USA |
 |
LivaNova PLC
LIVN
|
526 M | $ 62.29 | -0.93 % | $ 3.38 B |  Britain |
|
LENSAR
LNSR
|
26.5 M | $ 11.93 | -0.21 % | $ 137 M | USA |
 |
Second Sight Medical Products
EYES
|
806 K | - | -0.97 % | $ 54.4 M | USA |
 |
Align Technology
ALGN
|
1.76 B | $ 158.32 | -0.03 % | $ 11.9 B | USA |
 |
NanoVibronix
NAOV
|
3.46 M | - | - | $ 1.08 M | USA |
 |
Accuray Incorporated
ARAY
|
47.9 M | $ 0.81 | -1.31 % | $ 83.2 M | USA |
 |
Avinger
AVGR
|
14.1 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
12 M | $ 13.56 | -3.28 % | $ 366 M | USA |
 |
FONAR Corporation
FONR
|
23.5 M | $ 14.46 | 0.07 % | $ 94.8 M | USA |
 |
AxoGen
AXGN
|
39 M | $ 33.15 | 1.07 % | $ 1.47 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.2 M | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
8.88 M | - | -0.57 % | $ 7.12 M | USA |
 |
CONMED Corporation
CNMD
|
117 M | $ 41.41 | 1.57 % | $ 1.28 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
103 M | $ 17.7 | 2.08 % | $ 408 M | USA |
 |
Globus Medical
GMED
|
981 M | $ 88.34 | -0.08 % | $ 12 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
717 M | $ 12.58 | -0.32 % | $ 969 M | USA |
 |
Aziyo Biologics
AZYO
|
14.1 M | - | 1.37 % | $ 20.5 M | USA |